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Cyclic di-guanosine monophosphate is a bacterial second
messenger that has been implicated in biofilm formation, anti-
biotic resistance, and persistence of pathogenic bacteria in their
animal host. Although the enzymes responsible for the regula-
tion of cellular levels of c-di-GMP, diguanylate cyclases (DGC)
and phosphodiesterases, have been identified recently, little
information is available on the molecular mechanisms involved
in controlling the activity of these key enzymes or on the specific
interactions of c-di-GMPwith effector proteins. By using a com-
bination of genetic, biochemical, and modeling techniques we
demonstrate that an allosteric binding site for c-di-GMP (I-site)
is responsible for non-competitive product inhibition of DGCs.
The I-site was mapped in both multi- and single domain DGC
proteins and is fully contained within the GGDEF domain itself.
In vivo selection experiments and kinetic analysis of the evolved
I-sitemutants led to the definition of an RXXDmotif as the core
c-di-GMP binding site. Based on these results and based on the
observation that the I-site is conserved in a majority of known
and potential DGC proteins, we propose that product inhibi-
tion of DGCs is of fundamental importance for c-di-GMP
signaling and cellular homeostasis. The definition of the
I-site binding pocket provides an entry point into unraveling
the molecular mechanisms of ligand-protein interactions
involved in c-di-GMP signaling and makes DGCs a valuable
target for drug design to develop new strategies against bio-
film-related diseases.
A global signaling network that relies on the production of
the second messenger cyclic diguanylic acid has recently been
discovered in bacteria (1, 2). The c-di-GMP3 system emerges as
a regulatory mastermind orchestrating multicellular behavior
and biofilm formation in a wide variety of bacteria (2). In addi-
tion, c-di-GMP signaling also plays a role in bacterial virulence
and persistence (3–7). The broad importance of this novel sig-
naling molecule in pathogenic and non-pathogenic bacteria
calls for careful analysis of themolecularmechanisms that con-
trol cellular levels of c-di-GMP and regulate its downstream
targets. c-di-GMP is formed by the condensation of two GTP
molecules (8–10) and is hydrolyzed toGMPvia the linear inter-
mediate pGpG (11–14). Two widespread and highly conserved
bacterial protein domains have been implicated in the synthesis
and hydrolysis of c-di-GMP, respectively (15). The breakdown
of c-di-GMP is catalyzed by the EAL domain (12–14), and the
diguanylate cyclase (8) activity resides in the GGDEF domain
(10, 16). The highly conserved amino acid sequence GG(D/
E)EF forms part of the catalytically active site (A-site) of the
DGC enzyme (8). In agreement with this, mutations that
change the GG(D/E)EF motif generally abolish the activity of
the respective proteins (14, 16–18).
GGDEF domains are often found associated with sensor
domains, arguing that DGC activity is controlled by direct sig-
nal input through these domains (1). The best understood
example for controlled activation of a DGC is the response reg-
ulator PleD, which constitutes a timing device for Caulobacter
crescentus pole development (17, 19, 20). PleD is activated dur-
ing C. crescentus development by phosphorylation of an N-ter-
minal receiver domain and, as a result, sequesters to the differ-
entiating cell pole (17, 19). An additional layer of control was
suggested by the crystal structure of PleD solved recently in
complex with c-di-GMP (8) (Fig. 1). A c-di-GMP binding site
was identified in the crystal, spatially separated from the cata-
lytically active site (A-site). Two mutually intercalating c-di-
GMP molecules were found tightly bound to this site, at the
interface between the GGDEF and the central receiver-like
domain of PleD (Fig. 1). Based on the observation that PleD
activity shows a strong non-competitive product inhibition, it
was proposed that this site might constitute an allosteric bind-
ing site (I-site) (8). Based on the observation that functionally
important residues of the PleD I-site are highly conserved in a
majority of GGDEF proteins listed in the data base, we tested
the hypothesis that allosteric product inhibition is a general
regulatory principle of bacterial diguanylate cyclases.
MATERIALS ANDMETHODS
Strains, Plasmids, and Media—Escherichia coli and Salmo-
nella enterica serovar Typhimurium strains were grown in
Luria broth (LB). C. crescentus strains were grown in complex
peptone yeast extract (21). For DGC activity assays in vivo,
E. coliwas plated onto LB Congo Red plates (Sigma, 50 g/ml).
To determine the IPTG induction phenotype, 3 l of a liquid
log phase culture was spotted onto LB Congo Red plates with-
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out and with 1 mM IPTG. Biofilm formation was quantified
after overnight growth by staining with 1% Crystal Violet as
described (22). Motility phenotypes were determined using LB
or peptone yeast extract motility plates containing 0.3% Difco-
Agar. The exact procedure of strain and plasmid construction is
available on request.
Random I-site Tetrapeptide Library—The dgcA gene
(CC3285)was amplified by PCRusing primers #1006 and #1007
(for primer list see supplemental text). The PCR product was
digested with NdeI and XhoI and cloned into pET21a (Nova-
gen). In a next step adgcARESDallelewith a silent PstI restric-
tion site was generated by splicing with overlapping extension
PCR using primers #1129, #670, and #1132. The resulting PCR
product was digested with NdeI and XhoI and cloned into
pET42b (Novagen) to produce pET42::dgcARESD. The PstI/
XhoI fragment of pET42b::dgcARESD was replaced by 20
independent PCR products, which had been generated using
pET42b::dgcARESD as a template and primers #1131 and
#670. The resulting 20 independent random libraries were indi-
vidually transformed into E. coli BL21 and screened on Congo
Red plates (LB plates supplementedwith 50g/ml Congo Red).
As a control reaction, the deleted I-site was reverted back to the
wild-type RESD motif by cloning the PCR product generated
with primers #1130 and #670 into the PstI and XhoI site of
pET42b::dgcARESD.
Diguanylate Cyclase and Phosphodiesterase Activity Assays—
DGC reactions were performed at 30 °C with 0.5 M purified
hexahistidine-tagged DgcA or 5 M PleD in DGC reaction
buffer containing 250 mM NaCl, 25 mM Tris-Cl, pH 8.0, 5 mM
-mercaptoethanol, and 20 mM MgCl2. For inhibition assays
the protein was preincubated with different concentrations of
c-di-GMP (1–100 M) for 2 min at 30 °C before 100 M
[33P]GTP (Amersham Biosciences) was added. The reaction
was stopped at regular time intervals by adding an equal volume
of 0.5 M EDTA, pH 8.0. DGC/PDE tandem assays were carried
out using 1Mhexahistidine-taggedDgcA, which was preincu-
bated for 2 min in the presence or absence of 4.5 M hexahisti-
dine-tagged phosphodiesterase PdeA. The reaction was started
by adding 100 M [33P]GTP. The reactions were stopped at
regular time intervals of 15 s by adding equal volumes of 0.5 M
EDTA, pH 8.0, and their nucleotide composition was analyzed
as described below.
Initial velocity (Vo) and inhibition constants were deter-
mined by plotting the corresponding nucleotide concentration
versus time and by fitting the curve according to allosteric prod-
uct inhibited Michaelis-Menten kinetics with the program
ProFit 5.6.7 (with fit function [c-di-GMP]t a(1)*t/(a(2) t),
where the initial velocity Vo is defined as a(1)/a(2)) using the
Levenberg-Marquardt algorithm.Ki values were determined by
plotting Vo versus c-di-GMP concentration and using the fol-
lowing fit function, Vo[c-di-GMP] Vo[c-di-GMP] 0 *(1 ([c-di-
GMP]/(Ki [c-di-GMP])).
Polyethyleneimine Cellulose Chromatography—Samples were
dissolved in 5 l of running buffer containing 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60, and blotted on
Polygram CEL 300 polyethyleneimine cellulose TLC plates
(Macherey-Nagel). Plates were developed in 1:1.5 (v/v) satu-
rated NH4SO4 and 1.5 M KH2PO4, pH 3.60 (Rf(c-di-GMP) 0.2,
Rf(pGpG) 0.4), dried, and exposed on a storage phosphor imag-
ing screen (Amersham Biosciences). The intensity of the vari-
ous radioactive species was calculated by quantifying the inten-
sities of the relevant spots using ImageJ software version 1.33.
Vo and Ki were determined with the Software ProFit 5.6.7.
UVCross-linking with [33P]c-di-GMP—The 33P-labeled c-di-
GMP was produced enzymatically using [33P]GTP (3000
Ci/mmol) and purified according to a previous study (14). Pro-
tein samples were incubated for 10 min on ice in DGC reaction
buffer (25mMTris-HCl, pH 8.0, 250mMNaCl, 10mMMgCl2, 5
mM -mercaptoethanol) together with 1 M c-di-GMP and
33P-radiolabeled c-di-GMP (0.75Ci, 6000 Ci/mmol). Samples
were then irradiated at 254 nm for 20 min in an ice-cooled,
parafilm-wrapped 96-well aluminumblock in an RPR-100 pho-
tochemical reactor with a UV lamp RPR-3500 (Southern New
EnglandUltraviolet Co.). After irradiation, samples weremixed
with 2 SDS-PAGE sample buffer (250mMTris-HCl at pH 6.8,
40% glycerol, 8% SDS, 2.4 M -mercaptoethanol, 0.06% brom-
phenol blue, 40 mM EDTA) and heated for 5 min at 95 °C.
Labeled proteins were separated by SDS-PAGE and quantified
by autoradiography.
Nucleotide Extraction andAnalysis—2.0ml of E. coli cell cul-
tures (A600 0.4) were harvested by centrifugation, and superna-
tant was discarded. The cell pellet was dissolved in 200l of 0.5
M formic acid, and nucleotides were extracted for 10 min at
4 °C. Insoluble cell components were then pelleted, and the
supernatant was directly analyzed by chromatography. Nucle-
otides were extracted and separated according to a previous
study (23) on a 125/4 Nucleosil 4000-1 polyethyleneimine col-
umn (Macherey-Nagel) using the SMART-System (Amersham
Biosciences). The nucleotide peak corresponding to c-di-GMP
was verified by co-elution with a chemically synthesized c-di-
GMP standard.
DgcA Protein Expression Levels—DgcA protein expression
levels in E. coli BL21 were determined byWestern blot analysis
usingAnti-His(C-Term) antibody (Invitrogen) andhorseradish
peroxidase conjugate of goat anti-mouse IgG (Invitrogen) as
secondary antibody. The protein concentration was deter-
mined by measuring the intensities of the relevant spots using
ImageJ software version 1.33. Signals were calibrated to defined
concentrations of purified wild-type DgcA.
Molecular Modeling of PleD—All-atom simulations were
carried out using the CHARMM (24) program and the
CHARMM22/27 force field (25). For additional information
see the supplemental material.
RESULTS
Feedback Inhibition of the PleDDiguanylate Cyclase Requires
Binding of c-di-GMP to the I-site—The PleD crystal structure
indicated the existence of an allosteric binding pocket (I-site) at
the interface of theGGDEF and REC2 domains (8). Binding of a
c-di-GMP dimer in the I-site is mediated by specific electro-
static interactions with charged residues of the GGDEF and
REC2 domain (Fig. 1). To provide evidence for c-di-GMP bind-
ing to the I-site pocket in solution, trypsin digests were per-
formed with purified PleD protein (5 M) in the presence or
absence of c-di-GMP (25 M). The resulting peptide fragments
were separated on a C18 column and analyzed by matrix-as-
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sisted laser desorption ionization time-of-flight. Both chro-
matograms were identical, with the exception of two peaks that
were only detected in the absence of ligand but were protected
when c-di-GMP present during tryptic digest (supplemental
Fig. S1). One of the two peptides (T47, retention time 25.6min)
was identified by mass spectrometry and corresponds to the
amino acids 354–359 (supplemental Fig. S1), arguing that c-di-
GMP specifically protects from trypsin cleavage at Arg-359. To
provide additional evidence for ligand binding in solution, we
performedUVcross-linking assays using 33P-labeled c-di-GMP
(14). Residues Arg-148 and Arg-178 of the REC2 domain and
Arg-359, Asp-362, and Arg-390 of the GGDEF domain were
replaced with alanine, and the resulting protein variants were
analyzed. As shown in Fig. 2, mutating I-site residues of the
GGDEF domain abolished (R359D362) or strongly reduced
(R359A and R390A) c-di-GMP binding. In contrast, mutations
in theA-site (E370Q, E371Q, and EE370GG), which completely
abolished enzymatic activity (Table 1), had no effect on c-di-
GMP binding (Fig. 2), indicating that labeling with radioactive
c-di-GMP results from ligand binding at the I-site. Although
mutations R359A, R359V, R359D362, and D362A all
showed a dramatically reduced or complete loss of enzymatic
activity, mutant R390A showed wild-type-like DGC activity
(Table 1). In agreement with the reduced binding of c-di-GMP
(Fig. 2), the Ki of mutant R390A was increased20-fold (Table
1). PleD proteins harboring mutations in the REC2 portion of
the I-site (R148A and R178A) showed an increased binding
of c-di-GMP (Fig. 2) and slightly lower Ki values than wild
type (Table 1). Surprisingly, R148A/R178A single and double
mutants displayed a 5- to 20-fold higher DGC activity com-
pared with wild-type PleD (Table 1). Finally, c-di-GMP binding
was normal in mutant proteins that either lacked the REC1
receiver domain or had a bulky tryptophan residue introduced
at the REC2-GGDEF interface (G194W, Fig. 2). Together these
results implied that the structural requirements for c-di-GMP
binding are contained within the GGDEF domain of PleD and
that residues Arg-359, Asp-362, and Arg-390 form the core of
an allosteric binding pocket for c-di-GMP.
FIGURE 1. Crystal structure of the response regulator PleD. A, domain
architecture of PleD with receiver domain REC1 (blue), receiver domain REC2
(green), and GGDEF domain harboring diguanylate cyclase activity (red). The
active site (A-site) loop and the allosteric binding site (I-site) are indicated. B,
zoom in view of the I-site pocket with a bound dimer of c-di-GMP with inter-
calated purine bases. Residues Arg-148 and Arg-178 (green) from the REC2
domain and residues Arg-359, Asp-362, and Arg-390 (red) from the GGDEF
domain make specific contacts to the ligand in the crystal structure. C, sche-
matic of c-di-GMP synthesis and degradation reactions.
FIGURE 2. c-di-GMP labeling efficiency of different PleD mutants. The
upper lane shows autoradiographs of [33P]c-di-GMP UV cross-linked hexahis-
tidine-tagged PleD mutant proteins separated by SDS-PAGE. Relative label-
ing efficiencywith c-di-GMP is shownbelowwithwild-type PleD correspond-
ing to 100%. Specificmutants in different domains are colored in gray (REC1),
dark gray (REC2) and light gray (GGDEF).
Diguanylate Cyclase Feedback Control
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Evidence for an in Vivo Role of I-site-mediated Feedback
Control—To test a possible role for feedback inhibition of
diguanylate cyclases in vivo, we developed a simple assay based
on the observation that in E. coli and other Enterobacteriaceae
increased cellular levels of c-di-GMP correlate with Congo Red
(CR) staining of colonies on plates (28). Low level expression (in
the absence of the inducer IPTG) of active pleD alleles caused a
red colony phenotype in the E. coli B strain BL21, whereas cells
expressing inactive pleD alleles under the same conditions
stained white (Fig. 3). Interestingly, PleDmutants with dramat-
ically different diguanylate cyclase activities in vitro showed
only minor differences of CR staining in vivo. For instance,
PleDR148A/R178A, which showed a 20-fold increased activity
(Table 1), or PleD*, a constitutively active mutant of PleD sev-
eral 100-fold more active than wild-type (9), caused virtually
identical CR values like PleD wild type (Fig. 3). In contrast,
expression of the feedback inhibition mutant PleDR390A
resulted in a significantly higher CR staining even though its in
vitro DGC activity was lower than wild-type PleD (Table 1).
This argued that in vivo steady-state concentrations of c-di-
GMP were determined mainly by the PleD inhibition constant
(as opposed to the overall activity of the enzyme) and that a
functional I-site is critical for DGC control in vivo.
DgcA, a Single Domain Diguanylate Cyclase, Is Subject to
Allosteric Product Inhibition—Sequence alignments of 1000
annotated GGDEF domain proteins revealed that that I-site
residues Arg-359 and Asp-362 of PleD are highly conserved.
57% of the proteins containing a GGDEF domain and 27% of
GGDEF/EAL composite proteins possess this motif. This sug-
gested that c-di-GMP product inhibition could be a general
regulatorymechanism of bacterial diguanylate cyclases. To test
this, hexahistidine-tagged derivatives of two C. crescentus
GGDEF domain proteins were analyzed biochemically with
respect to their DGC activities and c-di-GMP binding proper-
ties. Purified DgcA (diguanylate cyclase A, CC3285), a soluble,
single domain GGDEF protein that lacks an obvious N-termi-
nal input domain, showed strong diguanylate cyclase activity
(Fig. 5A). DgcA has an RESDmotive five amino acids upstream
of the conservedGGDEFactive site andwas readily labeledwith
[33P]c-di-GMP in a cross-linking experiment (Fig. 4). Consist-
ent with this, DgcA showed strong feedback inhibition (Fig. 5A)
with its Ki (1 M) being in the same range as the inhibition
constant determined for PleD (8). In contrast, the GGDEF
domain of PdeA (phosphodiesterase A, CC3396), which lacks
catalytic activity (14), had no conserved I-site residues and did
not bind radiolabeled c-di-GMP (Fig. 4). Thus, specific binding
of c-di-GMP correlated with the presence of a conserved I-site
motif RXXD (Fig. 4).
Diguanylate cyclase activity assays revealed strong and rapid
product inhibition of DgcA. DgcA alone was able to convert
only a small fraction of the availableGTP substrate pool into the
product c-di-GMP (Vo  2.8 mol of c-di-GMP mol pro-
tein1 min1) (Fig. 5B). In contrast, GTP consumption and
conversion into c-di-GMP and pGpG was rapid (Vo  43.0
mol of c-di-GMP mol protein1 min1) and almost com-
plete when the PDE CC3396 was added in excess to the enzy-
matic reaction (Fig. 5B). This argued that c-di-GMP feedback
inhibition is abolished in a sequential DGC-PDE reaction,
because the steady-state concentration of the inhibitor c-di-
GMP is kept low by continuous degradation of c-di-GMP into
the linear dinucleotide pGpG. As a consequence of rapid feed-
back inhibition, the experimentally determinedVo values of the
DGC reaction are generally underestimated. In conclusion,
these results strengthen the view that allosteric product inhibi-
FIGURE 3. In vivo activity of different PleD and DgcA mutant proteins.
E. coli BL21 strains expressing different pleD alleles and dgcA wild type were
spotted onto Congo Red plates. Relative Congo Red bindingwas determined
using imageJ software with BL21 corresponding to 100%. FIGURE 4. UV cross-linking of different GGDEF domains with 33P-labeled
c-di-GMP. A, Coomassie-stained SDS-PAGE and B, autoradiograph of BSA
(control), PleDREC1,DgcA, and the isolatedGGDEFdomain of the c-di-GMP-
specific phosphodiesterase PdeA (CC3396) after UV cross-linking with [33P]c-
di-GMP. C, alignment of I- and A-site sequence of PleD, DgcA, and PdeA. I-site
(RXXD) and A-site residues (GGDEF) are marked in black and gray,
respectively.
Diguanylate Cyclase Feedback Control
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tion is a general principle of diguanylate cyclases and that high
affinity binding of c-di-GMP requires an RXXD I-site motif
positioned in close proximity to the active site.
Development of an in Vivo Assay to Genetically Probe Allos-
teric Control of DgcA—DGCs from different bacterial species
have been shown to be functionally interchangeable (17, 26, 27).
To determine if DgcA is active in vivo we expressed a plasmid-
based copy of the dgcA gene in C. crescentus, S. enterica, and
Escherichia coli B and tested the respective strains for the phe-
notypes known to result from increased cellular levels of c-di-
GMP (17, 26, 27). Consistentwith these earlier findings, expres-
sion of dgcA strongly inhibited flagellar-based motility in all
three organisms, dramatically increased the ability of S. enterica
and E. coli for surface colonization, and produced the charac-
teristic red, dry, and rough (rdar) colony morphotype when
plated on CR plates (Fig. 6, A–F) (29). The red phenotype pro-
vided the basis for a visual genetic screen on CR plates. Under
these conditions, cells producing active DgcA variants would
produce dark red single colonies, whereas cells producing inac-
tive DgcA mutants would remain white. This prompted us to
use the CR screen to isolate dgcAmutants, which had a specific
defect in feedback regulation, and to define the minimal
requirements for product inhibition of this class of enzymes.
Randomization of c-di-GMP Binding Pocket Reveals Three
Mutant Classes—To probe the minimal requirements of the
I-site for c-di-GMP binding and product inhibition, a dgcA
mutant library was constructed with the RESD signature
replaced by a randomized tetrapeptide sequence (see “Materi-
als and Methods”). In short, a dgcA gene, which carried a dele-
tion of the four I-site codons, was used as template for a PCR
reaction. For the amplification step a primer complementary to
the 3-end of dgcA was used in combination with a mixture of
oligonucleotides that spanned the deletion site and contained
12 randomized base pairs at the position coding for the deleted
amino acids. The resulting PCR fragments were fused in-frame
with the 5-end of dgcA in the expression plasmid pET42b and
were transformed into E. coli BL21. The resulting gene library
contains a theoretical number of 1.67 107 (412) different dgcA
alleles, coding for DgcA variants with different combinations of
I-site residues.
When plated onCR plates, colonies transformedwith a wild-
type dgcA allele showed the typical rdar colony morphology
(Fig. 6G). Transformation of E. coli BL21 with a plasmid
expressing a mutant DgcA, which lacked the four amino acids
of the I-site (DgcARESD), produced white colonies on CR
plates (Fig. 6H), indicating that this mutant form had lost DGC
activity. About 10% of the clones with random tetrapeptide
insertions stained red on CR plates and thus had retained DGC
activity (Fig. 6I). This result is consistent with the observation
that alanine scanning of the PleD I-site almost exclusively pro-
duced non-active enzyme variants (Table 1) and argues that the
majority of amino acid substitutions introduced at the I-site are
detrimental for the catalytic activity of the DGC. To further
characterize active DgcA I-site variants, a total of 800 red col-
onies was isolated and patched onto CR plates without (Fig. 6, J
andK) or with the inducer IPTG (Fig. 6, L andM). This second-
ary screen was based on the observation that IPTG-induced
expression of the pleDR390A allele (Table 1), but not of the
pleDwild-type allele, abolished growth of E. coli BL21 (data not
shown). This suggested that at elevated protein levels, DGCs
that lack feedback control are toxic in vivo (see below). The
majority of the I-site library clones tested failed to grow on
plates containing IPTG, indicating that their activity is no lon-
ger controlled by product inhibition (Fig. 6, L and M). Only 7
mutants (out of 9000 colonies screened) showed a wild type-
like behavior in that they stained dark red on CR plates and
tolerated the presence of the inducer IPTG (Fig. 6, L andM).
This genetic screen led to the isolation of three different
I-site mutant classes with the following characteristics: 1) cat-
alytically inactive mutants (A, frequency 90%); 2) feedback
control negative mutants (IA, frequency 10%); and wild-
type-like mutants (IA, frequency0.1%). A subset of class 1
and 2 mutants and all seven class 3 mutants were selected, and
hexahistidine-tagged forms of the respective proteins were
purified for biochemical characterization. Kinetic parameters
of activity (Vo) and feedback inhibition (Ki) were determined
FIGURE 5. c-di-GMP product inhibition of DgcA. A, initial velocities of the
wild-typediguanylate cyclaseDgcA (squares) and thenon-feedback inhibited
I-site mutant DgcA0244 (circles) in the presence of increasing concentrations
of c-di-GMP. B, conversion of GTP into c-di-GMP by DgcA (dashed lines) and
accelerated GTP consumption, c-di-GMP synthesis, and cleavage into pGpG
by a diguanylate cyclase-phosphodiesterase tandem reaction (plain lines).
Diguanylate Cyclase Feedback Control
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individually using an in vitro diguanylate cyclase activity assay
(16). Consistent with their rdar-like in vivo phenotype, only
class 2 and class 3 mutants showed detectable diguanylate
cyclase activity with an initial velocity between 1.93 and 14.21
mol of c-di-GMP mol protein1 min1 (Table 2). Only
mutant proteins from the IPTG tolerant class 3 showedproduct
inhibition with Ki values close to 1M (Table 2). In contrast, all
proteins from class 2mutants showed no feedback inhibition in
vitro, arguing that their in vivo toxicity is the result of uncon-
trolled run-off DGC activity (Fig. 5A and Table 2). Support for
this hypothesis comes from experiments determining the cel-
lular concentration of c-di-GMP and DgcA protein expression
levels in E. coli BL21 carrying selected dgcA alleles on plasmid
pET42b (see “Materials and Methods”). Alleles dgcA0244,
dgcA1229, and dgcA1250were chosen, because the DGC activ-
ity of these enzymes is similar towild typeDgcA (Table 2). Basal
level expression (no IPTG) of dgcA0244, the allele coding for a
DGC that completely lacks feedback inhibition, resulted in a
more than 100-fold increased cellular level of c-di-GMP as
compared with cells expressing wild-type dgcA (Table 3). This
was due to an almost 100-fold higher overall turnover of the
mutant enzyme as compared with wild type (Table 3). In con-
trast, enzymatic turnover and cellular concentration of c-di-
GMP was increased only marginally in E. coli cells expressing
alleles dgcA1229, and dgcA1250 with restored feedback inhibi-
tion control (Table 3).
Sequence analysis of the tetrapeptide insertions of class 2 and
class 3 mutants revealed several important characteristics of a
functional allosteric I-site binding pocket. All catalytically
active and feedback inhibition competent mutants restored the
wild-type Arg and Asp residues at positions one and four of the
RXXDmotive (Table 2).Whereas most of themutants that had
lost feedback inhibition had altered either one or both of these
charged residues (Table 2) only two feedback inhibition
mutants had retained both charges with changes in the inter-
vening residues (Table 2). Obviously, Arg and Asp, while being
strictly required for feedback inhibition, need to be placed in
the appropriate sequence context of the I-site loop. These
experiments define the minimal requirements of the I-site core
region and demonstrate that the Arg and Asp residues that
make direct contacts to the c-di-GMP ligand in the crystal
structure are of critical functional importance for DGC feed-
back inhibition in vivo and in vitro. This provides a plausible
FIGURE 6. Phenotypic characterization of ectopically expressed diguanylate cyclase dgcA in E. coli and S. enterica. Behavior of E. coli strain BL21 with
empty pET42b plasmid (A) and pET42b::dgcA (B) on motility plates. Colony morphology of E. coli strain BL21 with empty pET42b plasmid (C ) and with
pET42b::dgcA (D) on Congo Red plates. Biofilm formation of S. enterica serovar Typhimurium trp::T7RNAPwith empty pET42b (E ) and pET42b::dgcA (F ) grown
in liquid culture and stained with crystal violet. E. coli BL21 transformed with PCR-restored dgcA wild type on pET42b::dgcA (G), with the inactive allele
dgcARESD (pET42b::dgcARESD) (H), andwith a library of random tetrapeptide insertions in the I-site (pET42b::dgcAXXXX) (I) andplatedonCongoRedplates.
E. coliBL21 expressing different I-sitemutant alleleswere spotted ontoCongoRedplateswithout (J and K ) andwith 1mM IPTG (L andM) to screen for feedback
inhibition dgcA alleles.
TABLE 1
Kinetic analysis of PleDmutants
Protein Vo Vo Ki Ki
mol c-di-GMP/
(mol protein*min)
M
PleD wild type 0.202 	 0.023 5.8 	 1.0
PleDR359A 0.005 NDa 100 ND
PleDR359V 0.0 ND
PleD359362 0.0 ND
PleDD362A 0.0 ND
PleDR390A 0.076 	 0.007 115.0 	 18.1
PleDR148A 0.822 	 0.020 2.8 	 1.2
PleDR178A 0.918 	 0.292 3.6 	 0.1
PleDR148AR178A 3.75 	 0.43 2.9 	 0.6
PleDG194W 0.161 	 0.005 6.3 	 1.9
PleDEE370GG 0.0 ND
PleDE370Q 0.0 ND
PleDE371Q 0.0 ND
a ND, not determined.
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explanation for the strong conservation of the RXXD motif in
GGDEF domains.
The molecular mechanism of product inhibition through
I-site binding remains unclear. To assist the interpretation of
the present data and provide information on binding induced
mobility, atomistically detailed simulations were carried out.
Normal mode calculations on ligated and unligated PleD were
used to analyze the structural transitions that occur during
I-site binding of c-di-GMP. Normal mode calculations on the
optimized structures yielded no imaginary frequencies, and
translational and rotational frequencies were close to zero (
 0.02 cm1). This indicated that the minimized structures
correspond to real minima on the potential energy surface. The
displacements calculated for the ligated and the unligated pro-
tein showed a significant decrease in mobility for both I- and
A-site residues upon complexation (supplemental Figs. S2 and
S3). Whereas motion in the I-site is suppressed due to steric
interactions upon ligand insertion, quenching of the A-site res-
idues suggested that the two sitesmight be dynamically coupled
via the short connecting -strand (2). Backbone C-atoms
and side chains of the I-site and A-site loops were displaced by
an average of 1–4 Å in opposite directions, arguing that a bal-
ance-like movement centered around 2 could be responsible
for direct information transfer between the two sites (Fig. 7).
The cumulated displacements per residue over all 147 modes
(supplemental Fig. S3) showed differentmobilities in additional
regions of the protein. The C atoms of residues exhibiting
large changes in flexibility upon ligand binding are depicted as
spheres in supplemental Fig. S3. Reduced flexibility (yellow
spheres) is found at the I-site, A-site, phosphorylation site, and
the dimer interface, whereas the flexibility is enhanced (black
spheres) at the REC1/REC2 interface. In summary, these simu-
lations show that I-site binding of c-di-GMP not only reduced
the mobility around the RXXDmotif but also of the residues of
the A-site loop.
DISCUSSION
Feedback Inhibition Is a General Control Mechanism of
Diguanylate Cyclases—The data presented here propose a gen-
eral mechanism to regulate the activity of diguanylate cyclases
(DGCs), key enzymes of c-di-GMP-based signal transduction
in bacteria. High affinity binding of c-di-GMP to a site distant
from the catalytic pocket (I-site) efficiently blocks enzymatic
activity in a non-competitive manner. Mutational analysis of
multi- and single-domain DGC proteins has provided convinc-
ing evidence for the role of several charged amino acids in c-di-
GMP binding and allosteric regulation. Furthermore, these
experiments indicated that the allosteric binding site is func-
tionally contained within the GGDEF domain. An in vivo selec-
tion experiment using a random tetrapeptide library, and
TABLE 2
Diguanylate cyclase activity and inhibition constant of DgcA I-site mutant proteins
Protein Motif Vo Vo Ki Ki
mol c-di-GMP/
(mol proteinmin)
M
DgcA wt RESD 2.79 	 0.01 0.96 	 0.09
DgcA1406 RQGD 5.35 	 0.05 7.02 	 2.92
DgcA1040 RLVD 4.92 	 0.19 4.52 	 1.81
DgcA1229 RGAD 2.03 	 0.01 1.84 	 0.26
DgcA1524 RSAD 3.70 	 0.13 7.36 	 2.69
DgcA1529 RLAD 2.79 	 0.04 1.01 	 0.23
DgcA0751 RCAD 3.65 	 0.10 3.51 	 0.52
DgcA1250 RGGD 2.07 	 0.02 2.24 	 0.49
DgcARESD 0.14 	 0.06 NDa
DgcA0207 GMGG 14.21 	 0.54 No inhibition
DgcA0244 VMGG 2.57 	 0.05 No inhibition
DgcA0613 GGVA 4.29 	 0.06 No inhibition
DgcA0646 GRDC 8.90 	 0.10 No inhibition
DgcA0913 GVGD 3.81 	 0.04 No inhibition
DgcA1300 MEGD 0.87 	 0.02 No inhibition
DgcA1733 GGNH 11.47 	 0.17 No inhibition
DgcA3018 RESE 11.1 	 0.11 No inhibition
DgcA0230 RNRD 3.02 	 0.06 No inhibition
DgcA0642 RVDS 4.17 	 0.08 No inhibition
DgcA1007 RAGG 6.06 	 0.05 No inhibition
DgcA2006 RGQD 1.93 	 0.01 No inhibition
a ND, not determined.
TABLE 3
DgcA protein levels and cellular c-di-GMP concentrations in the absence or presence of IPTG induction at 1 mM
Protein conc.a c-di-GMP conc. Turnoverb
No induction 1 mM IPTG No induction 1 mM IPTG No induction 1 mM IPTG
pmol protein/mg dry weight pmol c-di-GMP/mg dry weight pmol c-di-GMP per pmol protein
DgcA0244 4.1 22 1466.3 1570.7 357.6 71.4
DgcA1229 3.5 31 87.6 139.5 25.0 4.5
DgcA1250 2.7 43 24.2 305.4 9.0 7.1
DgcA wt 2.9 33 13.75 189.4 4.7 5.7
DgcARESD 3.5 23 NDc ND NAd NA
a See “Materials and Methods.”
b As derived from the cellular c-di-GMP concentration divided by the cellular protein concentration.
c ND, not detectable.
d NA, not applicable.
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designed to re-engineer the I-site has led to the definition of a
highly conserved RXXD core motif of the c-di-GMP binding
pocket. The RXXD motif forms a turn at the end of a short
five-amino acid -sheet that directly connects the I-site with
the conserved catalytic A-site motif, GG(D/E)EF (Fig. 7). This
raised the question of how I-site ligand bindingmodulatesDGC
enzyme activity. In the multidomain protein PleD, c-di-GMP
bound to the I-site physically connects the GGDEF domain
with the REC1-REC2 dimerization stem. It was speculated that
product inhibition occurs by domain immobilization, which
would prevent the encounter of the twoDGC substrate binding
sites (8). Several observations argue in favor of a more direct
communication between I- and A-sites. First, with a large vari-
ety of domains found to be associated with GGDEF domains, it
seems unlikely that functional I-sites are generally formed by
the interface of a GGDEF with its neighboring domain (2). In
agreement with this, residues of the PleD REC2 domain are
not required for c-di-GMP binding and feedback inhibition.
Second, the single domain DGC protein, DgcA, shows I-site-
dependent allosteric control with aKi of 1M. Third, the intro-
duction of a bulky tryptophan residue (G194W) at the GGDEF-
REC2 interface did not affect activity, I-site binding, or
feedback inhibition of PleD (Fig. 2 and Table 1). Fourth, atom-
istic simulations of ligated and unligated PleD predicted a
marked drop in flexibility of C-atoms both in the I- and A-site
upon ligand binding. Simultaneous with motion quenching, 2
and its flanking I- and A-loops undergo a balance-like move-
ment that repositions A-site residues in the catalytic active site
(Fig. 7). This is consistent with the idea that structural changes
within the GGDEF domain upon binding of c-di-GMP at the
I-site lead to repositioning of active site residues and possibly
altered kinetic parameters. Thus, we propose that c-di-GMP
binding and allosteric control represents an intrinsic regulatory
property of DGCs that contain an RXXDmotif.
Like guanylate and adenylate cyclases (GCs and ACs) and
DNApolymerases,DGCs catalyze the nucleophilic attack of the
3-hydroxyl group on the -phosphate of a nucleoside triphos-
phate. Despite the lack of obvious sequence similarities, the
PleD x-ray structure revealed that DGCs possess a similar
domain architecture like ACs and GCs (8, 30). Based on muta-
tional analysis (8, 14, 16) and on structural comparisons
between DGC, AC, GC, and DNA polymerases (31–34), a
model for DGC catalysis can be proposed. In contrast to the
heterodimeric ACs and GCs, DGCs form homodimers, with a
GTP molecule bound within the catalytic core of each DGC
monomer (8). Two Mg2 ions are coordinated by the highly
conserved glutamic acid residue Glu-371, which is part of the
GGDEF motif, and possibly by Asp-327 on the opposing
-sheet. The divalent Mg2 carboxyl complex coordinates the
triphosphate moiety of GTP and activates the 3-hydroxyl
group for intermolecular nucleophilic attack. Substrate speci-
ficity of AC and GC can be interchanged by converting a few
key residues involved in purine recognition (31, 34, 35). This
includes an arginine residue, which in PleD corresponds to the
highly conservedArg-366 located in the-sheet connecting the
I- and A-sites. Based on the active site model, two alternative
inhibition mechanisms can be envisaged. In a first scenario,
binding of c-di-GMP to the I-site would change the orientation
of Arg-366 and would thereby disturb the guanine binding
pocket resulting in an increased Km for GTP. Alternatively,
inhibitor binding could rearrange the Mg2 carboxyl complex
and thus destabilize the active state.
In Silico Analysis of the GGDEF Protein Family Indicates
That Product Inhibition Is a General Regulatory Mechanism—
DGC activity of GGDEF domain proteins seems to strictly
depend on conserved GGDEF or GGEEF motifs in the active
site (10, 16, 18, 36–38). Consistent with this, 90% of the
GGDEF and 62% of the GGDEF/EAL composite proteins show
a conserved GG(D/E)EF A-site motif. Of the GGDEF proteins
with a highly conserved A-site motif, 60% have conserved
RXXD I-site residues and a conserved spacer length between I-
and A-site, arguing that the three-dimensional arrangement of
catalytic and allosteric pocket is likely to be similar in all DGCs.
From a total of 19 GGDEF proteins, for which convincing evi-
dence for a DGC activity exists, 14 have a conserved I-site (sup-
plemental Fig. S4). Ryjenkov and coworkers (10) reported
severe toxicity problems when expressing diguanylate cyclases
lacking I-site residues inE. coliBL21. This is consistentwith the
growth defect observed upon expression of dgcA feedback inhi-
bitionmutants inE. coliBL21 and argues that these proteins are
not feedback-controlled. The molecular basis of growth inter-
ference under these conditions is unclear. It is possible that
depletion of the GTP pool or adverse effects of unphysiologi-
cally high levels of c-di-GMP are responsible for this effect.
Although the experiments presented here define a role for the
I-site in DGC feedback inhibition, the c-di-GMP binding
pocket could also be exploited for other roles in c-di-GMP sig-
naling. It has been proposed recently that non-catalyticGGDEF
FIGURE 7. Comparison of the energy-minimized structures of the PleD
GGDEFdomainwithandwithout ligandbound to the I-site. For improved
clarity, the domain is sliced through the I-site loop/2/A-site loop plane. The
unligated protein is shown in gray and the I-site loop (green), 2 (black), and
A-site loop (gold ) of the bound structure are shown as an overlay. GTP bound
to the active site is modeled according to the orientation of c-di-GMP bound
to the A-site in the crystal structure. The PleD amino acid sequence of I-site,
2, and A-site is indicated below.
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domains with variant A-site motifs can fulfill regulatory func-
tions (14). It is attractive to speculate that a subgroupofGGDEF
proteins that has degenerate catalytic A-sites but conserved
c-di-GMP binding pockets, represents a novel class of c-di-
GMP effector proteins that regulate cellular functions in
response to c-di-GMP binding.
Regulatory Significance of DGC Feedback Control—GGDEF
domains are often associated with sensory domains in one- or
two-component signaling systems (39, 40). Thus it is reasona-
ble to assume that in most cases DGC activity is controlled by
direct signal input through these domains. But why then would
a substantial portion of these enzymes also be subject to feed-
back inhibition? There are several possibilities, which among
themselves are not mutually exclusive. Given the anticipated
regulatory complexity of the c-di-GMP signaling network (2,
39) and the potentially dramatic changes in cellular physiology
and behavior caused by fluctuating levels of c-di-GMP, it is in
the cell’s best interest to rigorously control the production of
the second messenger. Product inhibition of DGCs allows the
establishment of precise threshold concentrations of the sec-
ond messenger, or, in combination with counteracting PDEs,
could produce short spikes or even generate oscillations of c-di-
GMP. In addition, negative feedback loops have been impli-
cated in neutralizing noise and providing robustness in genetic
networks by limiting the range over which the concentrations
of the network components fluctuate (41, 42). Similarly, prod-
uct inhibition of DGCs could contribute to the reduction of
stochastic perturbations and increase the stability of the c-di-
GMP circuitry by keeping c-di-GMP levels in defined concen-
tration windows. Alternatively, DGC autoregulationmay influ-
ence the kinetics of c-di-GMP signaling. Mathematical
modeling and experimental evidence suggested that negative
autoregulation in combination with strong promoters substan-
tially shortens the rise-time of transcription responses (43–45).
In analogy, a desired steady-state concentration of c-di-GMP
can in principle be achieved by two regulatory designs: (a) a low
activity DGCwith no product inhibition, and (b) a high activity
DGC with built-in negative autoregulation. In cases where cir-
cuits have been optimized for fast up-kinetics, design B will be
superior. It is plausible that DGCs with or without I-site motifs
can be divided into these two kinetically different classes.
This study contributes to the emerging understanding of the
c-di-GMP regulatory network in bacteria. The current empha-
sis lies on the identification of effector molecules, regulatory
mechanisms, and processes controlled by c-di-GMP. With the
long term goal in mind of approaching a detailed systems-level
understanding of c-di-GMP signaling, kinetic parameters of
signalingmechanismswill require our particular attention.Our
experiments provide an entry point into the kinetic analysis of
individual DGCs and the quantitative assessment of the c-di-
GMP circuitry.
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 1 
SUPPLEMENTAL MATERIAL: 
 
MATERIALS AND METHODS: 
 
 
Purification of His-tagged proteins - E. coli BL21 cells carrying the respective expression 
plasmid were grown in LB medium with ampicillin (100μg/ml) or kanamycin (30μg/ml) and 
expression was induced by adding IPTG at OD600 0.4 to a final concentration of 0.4 mM. After 
harvesting by centrifugation, cells were resuspended in buffer containing 50 mM Tris-HCl, pH 
8.0, 250 mM NaCl, 5 mM -mercaptoethanol, lysed by passage through a French pressure cell, 
and the suspension was clarified by centrifugation for 10 min at 5,000 x g. Soluble and insoluble 
protein fractions were separated by a high-spin centrifugation step (100,000 x g, 1 h). The 
supernatant was loaded onto Ni-NTA affinity resin (Qiagen), washed with buffer, and eluted with 
an imidazol-gradient as recommended by the manufacturer. Protein preparations were examined 
for purity by SDS-PAGE and fractions containing pure protein were pooled and dialyzed for 12 h 
at 4°C. 
Molecular modeling of PleD  
All-atom simulations were carried out using the CHARMM (25) program and the 
CHARMM22/27 force field (26). The A chain of the X-ray dimer structure (PDB entry: 1W25 
(17)) was used. All titratable side chains were generated in their standard protonation state at pH 
7. Parameters and partial charges for the non-standard residue c-di-GMP were adopted from the 
extended CHARMM parameter sets for nucleic acids. The structure of the ligated (intercalated c-
di-GMP bound to the I-site) and the unligated protein, to which hydrogen atoms were added, 
were minimized using a distance-dependent dielectric with =4 and a cutoff of 12 Å for non-
bonded interactions. 5000 steps of steepest descent minimization were followed by adopted 
Newton Raphson minimization until a RMS gradient of 10-7 kcal/mol·Å was reached. Such a 
threshold is found to be sufficient for normal mode calculations (49). Normal modes were 
calculated with the diagonalization in a mixed basis (DIMB) method, as implemented in 
CHARMM. The DIMB method is an approximate scheme retaining the full atomistic description 
of the protein, where the Hessian is approximated iteratively. The total number of basis functions 
was 153 and cumulated displacements were calculated for T = 300 K.  
For ligated PleD motion is suppressed at L(1,1) (res.10-12), L(3,3) domain REC1, the C-
terminal end of 3 (res. 220-224) of domain REC2, the unstructured linker between REC2 and 
GGDEF domain (res. 282-284), the residues forming the A-site (res. 352), L(2,2) (res. 357-
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360, I-site), L(2,3) (res. 367-373, A-site) and at the C-terminal end of 3 (res. 396-398) of  the 
GGDEF domain. By contrast upon ligand binding mobility increases for 1 (res. 24), 4 (res. 96-
99) of domain REC1, residues (res. 149, 175), L(2,2) (res. 205-207), L(5,5) (res. 254-257) 
of domain REC2 and residues L(3',3'') (res. 404-407) and L(4,4) (res. 422-424) of the 
GGDEF domain. 
 
Primer list 
The following primers were used: #1006, ACA CGC TAC ATA TGA AAA TCT CAG GCG 
CCC GGA C; #1007, ACT CTC GAG AGC GCT CCT GCG CTT; #1129, CAA GCG GCT 
GCA GGC CAA TGT GAT CGT CGG CCG CAT GGG TGG TGA; #670, TGC TAG TTA TTG 
CTC AGC GG; #1006 ACA CGC TAC ATA TGA AAA TCT CAG GCG CCC GGA C; #1130, 
CAA GCG GCT GCA GGC CAA TGT GCG CGA AAG CGA CAT CGT CGG CCG CAT 
GGG TGG TGA; #1132, CAC ATT GGC CTG CAG CCG CTT GGC GAC; #1131, CAA GCG 
GCT GCA GGC CAA TGT GNN NNN NNN NNN NAT CGT CGG CCG CAT GGG TGG 
TGA.  
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FIGURE LEGENDS: 
Figure S1: Separation of peptides yielded from tryptic digest of PleD in the presence (red 
chromatogram) or absence of c-di-GMP (black chromatogram) on a C18 column. Peaks 
identified by ESI-MS: c-di-GMP m/z 691, tR 7.70 min, T47 (amino acids 354-359) m/z 659.3 tR 
25.64 min. T49 (amino acids 367-386) m/z 2167.7 tR 47.73 min. 
 
Figure S2: Normal modes of PleD I-site and A-site residues. The displacements for each mode 
of the ligated and unligated structures are shown in Å for the residues of the REC2 domain 
(green) and the GGDEF domain (red). Insertion of intercalated c-di-GMP in the I-site quenches 
motion in both the I-site (R359-D362, R390) and the A-site (G368-E371), suggesting that the two 
sites are dynamically coupled. 
 
Figure S3: Representation of the PleD protein (blue: REC1, green: REC2, red: DGC) with c-
di-GMP bound to the I-site. C-atoms at positions of considerable changes in flexibility upon 
ligand binding are shown as spheres; reduced flexibility (yellow) and enhanced flexibility (black). 
Note that binding of c-di-GMP at the I-site (I) affects mobility not only in the I-site, but also in 
other regions of the protein, e.g. A-site (A), phosphorylation site (P) and dimer interface. 
 
Figure S4: Alignment of I- and A-site sequence of biochemically characterized diguanylate 
cyclases.  I-site residues (RXXD) are underlined in green and A-site residues (GGDEF) are 
underlined in yellow. 
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